SCI Pharmtech Inc
TWSE:4119
SCI Pharmtech Inc
Inventory
SCI Pharmtech Inc
Inventory Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Inventory | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
S
|
SCI Pharmtech Inc
TWSE:4119
|
Inventory
NT$620.9m
|
CAGR 3-Years
28%
|
CAGR 5-Years
3%
|
CAGR 10-Years
2%
|
|
|
Y
|
YungShin Global Holding Corp
TWSE:3705
|
Inventory
NT$3.1B
|
CAGR 3-Years
1%
|
CAGR 5-Years
5%
|
CAGR 10-Years
8%
|
|
|
ScinoPharm Taiwan Ltd
TWSE:1789
|
Inventory
NT$1.7B
|
CAGR 3-Years
8%
|
CAGR 5-Years
8%
|
CAGR 10-Years
-4%
|
|
|
Lotus Pharmaceutical Co Ltd
TWSE:1795
|
Inventory
NT$3.8B
|
CAGR 3-Years
8%
|
CAGR 5-Years
23%
|
CAGR 10-Years
14%
|
|
|
Standard Chem & Pharm Co Ltd
TWSE:1720
|
Inventory
NT$1.7B
|
CAGR 3-Years
12%
|
CAGR 5-Years
13%
|
CAGR 10-Years
9%
|
|
|
C
|
Caliway Biopharmaceuticals Co Ltd
TWSE:6919
|
Inventory
NT$2.9m
|
CAGR 3-Years
299%
|
CAGR 5-Years
170%
|
CAGR 10-Years
N/A
|
|
SCI Pharmtech Inc
Glance View
SCI Pharmtech Corp. is engaged in the biotechnology and medical care industry. The company is headquartered in Taoyuan, Taoyuan. The company went IPO on 2002-08-12. The firm's main products include APIs, API intermediates and special and precision chemicals. The firm distributes its products in domestic market and to overseas markets, including Europe, the Americas, the rest areas of Asia and others
See Also
What is SCI Pharmtech Inc's Inventory?
Inventory
620.9m
TWD
Based on the financial report for Dec 31, 2024, SCI Pharmtech Inc's Inventory amounts to 620.9m TWD.
What is SCI Pharmtech Inc's Inventory growth rate?
Inventory CAGR 10Y
2%
Over the last year, the Inventory growth was 17%. The average annual Inventory growth rates for SCI Pharmtech Inc have been 28% over the past three years , 3% over the past five years , and 2% over the past ten years .
You don't have any saved screeners yet